TCT-248 Absorb bioresorbable vascular scaffold in patients with or without diabetes mellitus: a sub-analysis of the Italian multicenter RAI Registry ( ClinicalTrials.gov Identifier: NCT02298413)
Patients treated with Absorb BVS because of in-stent restenosis or bypass graft disease were excluded from current analysis. At 1-year follow-up, no differences were found between groups in terms of a device-oriented composite end-point (DOCE) (4.3% vs. 6.6%; p=0.6) or its individual components (car...
Gespeichert in:
| Veröffentlicht in: | Journal of the American College of Cardiology 2017-10, Vol.70 (18), p.B103-B103 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | B103 |
|---|---|
| container_issue | 18 |
| container_start_page | B103 |
| container_title | Journal of the American College of Cardiology |
| container_volume | 70 |
| creator | Mojoli, Marco Tarantini, Giuseppe Masiero, Giulia Loi, Bruno Cortese, Bernardo Ielasi, Alfonso Varricchio, Attilio Moretti, Luciano Misuraca, Leonardo Pasquetto, Giampaolo Calabro', Paolo Corrado, Donatella Steffenino, Giuseppe |
| description | Patients treated with Absorb BVS because of in-stent restenosis or bypass graft disease were excluded from current analysis. At 1-year follow-up, no differences were found between groups in terms of a device-oriented composite end-point (DOCE) (4.3% vs. 6.6%; p=0.6) or its individual components (cardiac death, target-vessel myocardial infarction and ischemia-driven TLR). |
| doi_str_mv | 10.1016/j.jacc.2017.09.321 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1957884822</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109717401094</els_id><sourcerecordid>1957884822</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1681-54c720d9733d533921c7e05a1dd56c7d9717d277d737e7aef85b127199f03ee93</originalsourceid><addsrcrecordid>eNp9UcuOEzEQHCGQCAs_wKklLnCYwY9MPF5xiUY8Iq1AWg1ny2P37DpyxsH2ZJXf48twCGdO1VJXlbq6quotJQ0ldPNx3-y1MQ0jVDRENpzRZ9WKtm1X81aK59WKCN7WlEjxsnqV0p4QsumoXFW_h36o2bqD7ZhCHGF0IeJl0qNHOOlkFq8jJKOnKXgLboajzg7nnODJ5UcI8S-GJYN1esSMCQ7ovctLugUNaRlrPWt_Ti5BmCA_Iuyy9k7PcFh8dqZ4YYT77Q7u8cGlHM_wHnrvZme0H6LTPjUP4QQ7W5huchhv4Xs_EMZkt6b8w-vqxVQ4-OYf3lQ_v3we-m_13Y-vu357Vxtastbt2ghGrBSc25ZzyagRSFpNrW03RpQFFZYJYQUXKDROXTtSJqiUE-GIkt9U766-xxh-LZiy2ocllmhJUdmKrlt3jBUWu7JMDClFnNQxuoOOZ0WJunSl9urSlbp0pYhUpasi-nQVYbn_VBKqZMqPDVoX0WRlg_uf_A_Kk51p</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1957884822</pqid></control><display><type>article</type><title>TCT-248 Absorb bioresorbable vascular scaffold in patients with or without diabetes mellitus: a sub-analysis of the Italian multicenter RAI Registry ( ClinicalTrials.gov Identifier: NCT02298413)</title><source>Access via ScienceDirect (Elsevier)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Mojoli, Marco ; Tarantini, Giuseppe ; Masiero, Giulia ; Loi, Bruno ; Cortese, Bernardo ; Ielasi, Alfonso ; Varricchio, Attilio ; Moretti, Luciano ; Misuraca, Leonardo ; Pasquetto, Giampaolo ; Calabro', Paolo ; Corrado, Donatella ; Steffenino, Giuseppe</creator><creatorcontrib>Mojoli, Marco ; Tarantini, Giuseppe ; Masiero, Giulia ; Loi, Bruno ; Cortese, Bernardo ; Ielasi, Alfonso ; Varricchio, Attilio ; Moretti, Luciano ; Misuraca, Leonardo ; Pasquetto, Giampaolo ; Calabro', Paolo ; Corrado, Donatella ; Steffenino, Giuseppe</creatorcontrib><description>Patients treated with Absorb BVS because of in-stent restenosis or bypass graft disease were excluded from current analysis. At 1-year follow-up, no differences were found between groups in terms of a device-oriented composite end-point (DOCE) (4.3% vs. 6.6%; p=0.6) or its individual components (cardiac death, target-vessel myocardial infarction and ischemia-driven TLR).</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/j.jacc.2017.09.321</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Biocompatibility ; Biomedical materials ; Cardiology ; Diabetes ; Diabetes mellitus ; Patients ; Stents ; Surgical implants</subject><ispartof>Journal of the American College of Cardiology, 2017-10, Vol.70 (18), p.B103-B103</ispartof><rights>2017</rights><rights>Copyright Elsevier Limited Oct 31, 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jacc.2017.09.321$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids></links><search><creatorcontrib>Mojoli, Marco</creatorcontrib><creatorcontrib>Tarantini, Giuseppe</creatorcontrib><creatorcontrib>Masiero, Giulia</creatorcontrib><creatorcontrib>Loi, Bruno</creatorcontrib><creatorcontrib>Cortese, Bernardo</creatorcontrib><creatorcontrib>Ielasi, Alfonso</creatorcontrib><creatorcontrib>Varricchio, Attilio</creatorcontrib><creatorcontrib>Moretti, Luciano</creatorcontrib><creatorcontrib>Misuraca, Leonardo</creatorcontrib><creatorcontrib>Pasquetto, Giampaolo</creatorcontrib><creatorcontrib>Calabro', Paolo</creatorcontrib><creatorcontrib>Corrado, Donatella</creatorcontrib><creatorcontrib>Steffenino, Giuseppe</creatorcontrib><title>TCT-248 Absorb bioresorbable vascular scaffold in patients with or without diabetes mellitus: a sub-analysis of the Italian multicenter RAI Registry ( ClinicalTrials.gov Identifier: NCT02298413)</title><title>Journal of the American College of Cardiology</title><description>Patients treated with Absorb BVS because of in-stent restenosis or bypass graft disease were excluded from current analysis. At 1-year follow-up, no differences were found between groups in terms of a device-oriented composite end-point (DOCE) (4.3% vs. 6.6%; p=0.6) or its individual components (cardiac death, target-vessel myocardial infarction and ischemia-driven TLR).</description><subject>Biocompatibility</subject><subject>Biomedical materials</subject><subject>Cardiology</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Patients</subject><subject>Stents</subject><subject>Surgical implants</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9UcuOEzEQHCGQCAs_wKklLnCYwY9MPF5xiUY8Iq1AWg1ny2P37DpyxsH2ZJXf48twCGdO1VJXlbq6quotJQ0ldPNx3-y1MQ0jVDRENpzRZ9WKtm1X81aK59WKCN7WlEjxsnqV0p4QsumoXFW_h36o2bqD7ZhCHGF0IeJl0qNHOOlkFq8jJKOnKXgLboajzg7nnODJ5UcI8S-GJYN1esSMCQ7ovctLugUNaRlrPWt_Ti5BmCA_Iuyy9k7PcFh8dqZ4YYT77Q7u8cGlHM_wHnrvZme0H6LTPjUP4QQ7W5huchhv4Xs_EMZkt6b8w-vqxVQ4-OYf3lQ_v3we-m_13Y-vu357Vxtastbt2ghGrBSc25ZzyagRSFpNrW03RpQFFZYJYQUXKDROXTtSJqiUE-GIkt9U766-xxh-LZiy2ocllmhJUdmKrlt3jBUWu7JMDClFnNQxuoOOZ0WJunSl9urSlbp0pYhUpasi-nQVYbn_VBKqZMqPDVoX0WRlg_uf_A_Kk51p</recordid><startdate>20171031</startdate><enddate>20171031</enddate><creator>Mojoli, Marco</creator><creator>Tarantini, Giuseppe</creator><creator>Masiero, Giulia</creator><creator>Loi, Bruno</creator><creator>Cortese, Bernardo</creator><creator>Ielasi, Alfonso</creator><creator>Varricchio, Attilio</creator><creator>Moretti, Luciano</creator><creator>Misuraca, Leonardo</creator><creator>Pasquetto, Giampaolo</creator><creator>Calabro', Paolo</creator><creator>Corrado, Donatella</creator><creator>Steffenino, Giuseppe</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20171031</creationdate><title>TCT-248 Absorb bioresorbable vascular scaffold in patients with or without diabetes mellitus: a sub-analysis of the Italian multicenter RAI Registry ( ClinicalTrials.gov Identifier: NCT02298413)</title><author>Mojoli, Marco ; Tarantini, Giuseppe ; Masiero, Giulia ; Loi, Bruno ; Cortese, Bernardo ; Ielasi, Alfonso ; Varricchio, Attilio ; Moretti, Luciano ; Misuraca, Leonardo ; Pasquetto, Giampaolo ; Calabro', Paolo ; Corrado, Donatella ; Steffenino, Giuseppe</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1681-54c720d9733d533921c7e05a1dd56c7d9717d277d737e7aef85b127199f03ee93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Biocompatibility</topic><topic>Biomedical materials</topic><topic>Cardiology</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Patients</topic><topic>Stents</topic><topic>Surgical implants</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mojoli, Marco</creatorcontrib><creatorcontrib>Tarantini, Giuseppe</creatorcontrib><creatorcontrib>Masiero, Giulia</creatorcontrib><creatorcontrib>Loi, Bruno</creatorcontrib><creatorcontrib>Cortese, Bernardo</creatorcontrib><creatorcontrib>Ielasi, Alfonso</creatorcontrib><creatorcontrib>Varricchio, Attilio</creatorcontrib><creatorcontrib>Moretti, Luciano</creatorcontrib><creatorcontrib>Misuraca, Leonardo</creatorcontrib><creatorcontrib>Pasquetto, Giampaolo</creatorcontrib><creatorcontrib>Calabro', Paolo</creatorcontrib><creatorcontrib>Corrado, Donatella</creatorcontrib><creatorcontrib>Steffenino, Giuseppe</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mojoli, Marco</au><au>Tarantini, Giuseppe</au><au>Masiero, Giulia</au><au>Loi, Bruno</au><au>Cortese, Bernardo</au><au>Ielasi, Alfonso</au><au>Varricchio, Attilio</au><au>Moretti, Luciano</au><au>Misuraca, Leonardo</au><au>Pasquetto, Giampaolo</au><au>Calabro', Paolo</au><au>Corrado, Donatella</au><au>Steffenino, Giuseppe</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TCT-248 Absorb bioresorbable vascular scaffold in patients with or without diabetes mellitus: a sub-analysis of the Italian multicenter RAI Registry ( ClinicalTrials.gov Identifier: NCT02298413)</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2017-10-31</date><risdate>2017</risdate><volume>70</volume><issue>18</issue><spage>B103</spage><epage>B103</epage><pages>B103-B103</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Patients treated with Absorb BVS because of in-stent restenosis or bypass graft disease were excluded from current analysis. At 1-year follow-up, no differences were found between groups in terms of a device-oriented composite end-point (DOCE) (4.3% vs. 6.6%; p=0.6) or its individual components (cardiac death, target-vessel myocardial infarction and ischemia-driven TLR).</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/j.jacc.2017.09.321</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0735-1097 |
| ispartof | Journal of the American College of Cardiology, 2017-10, Vol.70 (18), p.B103-B103 |
| issn | 0735-1097 1558-3597 |
| language | eng |
| recordid | cdi_proquest_journals_1957884822 |
| source | Access via ScienceDirect (Elsevier); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Biocompatibility Biomedical materials Cardiology Diabetes Diabetes mellitus Patients Stents Surgical implants |
| title | TCT-248 Absorb bioresorbable vascular scaffold in patients with or without diabetes mellitus: a sub-analysis of the Italian multicenter RAI Registry ( ClinicalTrials.gov Identifier: NCT02298413) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T23%3A30%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TCT-248%20Absorb%20bioresorbable%20vascular%20scaffold%20in%20patients%20with%20or%20without%20diabetes%20mellitus:%20a%20sub-analysis%20of%20the%20Italian%20multicenter%20RAI%20Registry%20(%20ClinicalTrials.gov%20Identifier:%20NCT02298413)&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Mojoli,%20Marco&rft.date=2017-10-31&rft.volume=70&rft.issue=18&rft.spage=B103&rft.epage=B103&rft.pages=B103-B103&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/j.jacc.2017.09.321&rft_dat=%3Cproquest_cross%3E1957884822%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1957884822&rft_id=info:pmid/&rft_els_id=S0735109717401094&rfr_iscdi=true |